These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26518649)

  • 21. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.
    Nehoff H; Parayath NN; Domanovitch L; Taurin S; Greish K
    Int J Nanomedicine; 2014; 9():2539-55. PubMed ID: 24904213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonoproduction of liposomes and protein particles as templates for delivery purposes.
    Silva R; Ferreira H; Cavaco-Paulo A
    Biomacromolecules; 2011 Oct; 12(10):3353-68. PubMed ID: 21905662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agents.
    Sagnella SM; Gong X; Moghaddam MJ; Conn CE; Kimpton K; Waddington LJ; Krodkiewska I; Drummond CJ
    Nanoscale; 2011 Mar; 3(3):919-24. PubMed ID: 21173998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanodiamond-Based Composite Structures for Biomedical Imaging and Drug Delivery.
    Rosenholm JM; Vlasov II; Burikov SA; Dolenko TA; Shenderova OA
    J Nanosci Nanotechnol; 2015 Feb; 15(2):959-71. PubMed ID: 26353602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Entering the era of nanoscience: time to be so small.
    Uskoković V
    J Biomed Nanotechnol; 2013 Sep; 9(9):1441-70. PubMed ID: 23980495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocompatible dispersions of carbon nanotubes: a potential tool for intracellular transport of anticancer drugs.
    Di Crescenzo A; Velluto D; Hubbell JA; Fontana A
    Nanoscale; 2011 Mar; 3(3):925-8. PubMed ID: 21180768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals.
    Gaspar R
    Nanomedicine (Lond); 2007 Apr; 2(2):143-7. PubMed ID: 17716116
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate.
    Fontana MC; Rezer JF; Coradini K; Leal DB; Beck RC
    Eur J Pharm Biopharm; 2011 Oct; 79(2):241-9. PubMed ID: 21605671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interview with Professor Jindřich Kopeček.
    Kopeček J; Stanwix H
    Nanomedicine (Lond); 2014 Apr; 9(5):577-9. PubMed ID: 24827841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.
    Su CW; Chiang CS; Li WM; Hu SH; Chen SY
    Nanomedicine (Lond); 2014 Jul; 9(10):1499-515. PubMed ID: 25253498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use.
    Limayem Blouza I; Charcosset C; Sfar S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytotoxicity of metal-encapsulating carbon nanocapsules.
    Uo M; Tamura K; Sato Y; Yokoyama A; Watari F; Totsuka Y; Tohji K
    Small; 2005 Aug; 1(8-9):816-9. PubMed ID: 17193530
    [No Abstract]   [Full Text] [Related]  

  • 33. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicine as an emerging approach against intracellular pathogens.
    Armstead AL; Li B
    Int J Nanomedicine; 2011; 6():3281-93. PubMed ID: 22228996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic Synthesis of Large-Pore and Well-Dispersed Benzene Bridged Mesoporous Organosilica Nanoparticles for Intracellular Protein Delivery.
    Yang Y; Niu Y; Zhang J; Meka AK; Zhang H; Xu C; Lin CX; Yu M; Yu C
    Small; 2015 Jun; 11(23):2743-9. PubMed ID: 25652950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges for metals in medicine: how nanotechnology may help to shape the future.
    Barry NP; Sadler PJ
    ACS Nano; 2013 Jul; 7(7):5654-9. PubMed ID: 23837396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle therapeutics: a personal perspective.
    McNeil SE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanomedicine: An unresolved regulatory issue.
    Chan VS
    Regul Toxicol Pharmacol; 2006 Dec; 46(3):218-24. PubMed ID: 17081666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taking temperature--a review of European Union regulation in nanomedicine.
    D'Silva J; van Calster G
    Eur J Health Law; 2009 Sep; 16(3):249-69. PubMed ID: 19788003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation and stability evaluation of bixin nanocapsules.
    Lobato KB; Paese K; Forgearini JC; Guterres SS; Jablonski A; Rios Ade O
    Food Chem; 2013 Dec; 141(4):3906-12. PubMed ID: 23993564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.